losartan + valsartan

Losartan + valsartan is a hypothetical combination of two angiotensin II receptor blockers (ARBs): losartan and valsartan. Both drugs individually block the angiotensin II type 1 receptor, leading to vasodilation, reduced secretion of aldosterone, and decreased blood pressure. They are primarily used for the treatment of hypertension and related cardiovascular conditions. While both agents are effective as monotherapy or in combination with other antihypertensive classes (such as thiazide diuretics or calcium channel blockers), there is no evidence that a fixed-dose combination product containing only losartan and valsartan exists or is approved for clinical use. Combining two ARBs is generally not recommended due to overlapping mechanisms without added benefit and potential increased risk of adverse effects such as hyperkalemia, hypotension, or renal impairment[1][2][5][7].